GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Change in Other Operating Liabilities (2022 - 2024)

Updated

GT Biopharma (GTBP) recorded Change in Other Operating Liabilities of -$58,000 in FY2024, compared with -$116,000 in FY2023.

Analysis

GT Biopharma (GTBP) Change in Other Operating Liabilities (2022 - 2024) Analysis & Trends

Starting with FY2018, GT Biopharma's Change in Other Operating Liabilities history includes 4 years.

  • The FY2024 figure is the highest annual Change in Other Operating Liabilities since FY2018.
  • Per Business Quant data, GTBP's Change in Other Operating Liabilities was -$116,000 in FY2023 and -$86,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.69 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -113.00 Mn
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -30,000.00
Mar 31, 2024 -28,000.00
Dec 31, 2023 -34,000.00
Sep 30, 2023 -28,000.00
Jun 30, 2023 -27,000.00
Mar 31, 2023 -27,000.00
Dec 31, 2022 -24,000.00
Sep 30, 2022 -25,000.00
Jun 30, 2022 -24,000.00
Mar 31, 2022 -13,000.00
API Access

GT Biopharma Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=GTBP&period=max&api_key=YOUR_API_KEY